Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Lian, Feng ^a   Cui, Yong ^a   Zhou, Chenliang ^a   Gao, Kewei ^a   Wu, Liwen ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 195 5P; MICRORNA 199A 3P; MICRORNA 320A; MICRORNA 374A 5P; TUMOR MARKER; UNCLASSIFIED DRUG; MICRORNA;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CANCER PROGNOSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; ORTHOPEDIC SURGERY; OSTEOSARCOMA; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIMARY TUMOR; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UPREGULATION; ADULT; BLOOD; CASE CONTROL STUDY; CHILD; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; REPRODUCIBILITY; TREATMENT OUTCOME; TUMOR VOLUME; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; CHILD; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRORNAS; NEOPLASM METASTASIS; OSTEOSARCOMA; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TUMOR BURDEN; YOUNG ADULT;

EID: 84925014239     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121499     Document Type: Article

References (22)

1. Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, Nuovo GJ, et al. miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res. 2012;72(7):1865-1877. doi: 10. 1158/0008-5472. CAN-11-2663 PMID: 22350417
2. Yang J, Zhang W. New molecular insights into osteosarcoma targeted therapy. Curr Opin Oncol. 2013;25(4):398-406. doi: 10.1097/CCO.0b013e3283622c1b PMID: 23666471
3. Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1, 702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002;20(3):776-790. PMID: 11821461
4. Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350-355. PMID: 15372042
5. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120(1):15-20. PMID: 15652477
6. Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006;11(4):441-450. PMID: 17011485
7. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18(10):997-1006. doi: 10.1038/cr.2008.282 PMID: 18766170
8. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105(30):10513-10518. doi: 10.1073/pnas.0804549105 PMID: 18663219
9. Ouyang L, Liu P, Yang S, Ye S, Xu W, Liu X. A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma. Med Oncol. 2013;30(1):340. doi: 10.1007/s12032-012-0340-7 PMID: 23269581
10. Tian Q, Jia J, Ling S, Liu Y, Yang S, Shao Z. A causal role for circulating miR-34b in osteosarcoma. Eur J Surg Oncol. 2014;40(1):67-72. doi: 10.1016/j.ejso.2013.08.024 PMID: 24063968
11. Yuan J, Chen L, Chen X, Sun W, Zhou X. Identification of serum microRNA-21 as a biomarker for chemosensitivity and prognosis in human osteosarcoma. J Int Med Res. 2012;40(6):2090-2097. PMID: 23321165
12. Chen X, Hu Z, Wang W, Ba Y, Ma L, Zhang C, et al. Identification of ten serum microRNAs from a genomewide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Int J Cancer. 2012;130(7):1620-1628. doi: 10.1002/ijc.26177 PMID: 21557218
13. Zen K, Zhang CY. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev. 2012;32(2):326-348. doi: 10.1002/med.20215 PMID: 22383180
14. Marina N, Gebhardt M, Teot L, Gorlick R. Biology and therapeutic advances for pediatric osteosarcoma. Oncologist. 2004;9(4):422-441. PMID: 15266096
15. Bielack SS, Marina N, Ferrari S, Helman LJ, Smeland S, Whelan JS, et al. Osteosarcoma: the same old drugs or more? J Clin Oncol. 2008;26(18):3102-3103; author reply 3104-3105. doi: 10.1200/JCO. 2008.17.1108 PMID: 18565904
16. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol. 2008;141(5):672-675. doi: 10.1111/j.1365-2141.2008.07077.x PMID: 18318758
17. Liu R, Zhang C, Hu Z, Li G, Wang C, Yang C, et al. A five-microRNA signature identified from genomewide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer. 2011;47(5):784-791. doi: 10.1016/j.ejca.2010.10.025 PMID: 21112772
18. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281-297. PMID: 14744438
19. Bacci G, Longhi A, Versari M, Mercuri M, Briccoli A, Picci P. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer. 2006;106(5):1154-1161. PMID: 16421923
20. Mao JH, Zhou RP, Peng AF, Liu ZL, Huang SH, Long XH, et al. microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN. Oncol Lett. 2012;4(5):1125-1129. PMID: 23162665
21. Tian Y, Zhang YZ, Chen W. MicroRNA-199a-3p and microRNA-34a regulate the apoptosis in human osteosarcoma cells. Biosci Rep. 2014.
22. Duan Z, Choy E, Harmon D, Liu X, Susa M, Mankin H, et al. MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. Mol Cancer Ther. 2011;10(8):1337-1345. doi: 10.1158/1535-7163. MCT-11-0096 PMID: 21666078